Does switching the bacillus Calmette-Guerin strain affect clinical outcome in patients with recurrent non–muscle-invasive bladder cancer after initial bacillus Calmette-Guerin therapy?
Urologic Oncology: Seminars and Original Investigations | Mar 15, 2018